KORU Medical Systems - KRMD Real Price to Acquire Entire Company

Official company branding of korumedical.com (KRMD)

This price chart illustrates the value dynamics of KORU Medical Systems (KRMD), which has a valuation of 141.39. The business relies on a diversified warehouse network to ensure the seamless delivery of infusion systems. KORU Medical Systems (KRMD) dominates the home therapy segment by employing a strategy that locks users into its own accessories. This ensures a steady cash flow through the sale of high-cost disposable components and strong pricing power.

KRMD (KORU Medical Systems) Total Company Value history from 11/23/2025 to 10/28/2026

KRMD (KORU Medical): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Performance Chart KORU Medical Systems, Inc.|KRMD - Price Target Chart
- market capitalization data:
Market Valuation KORU Medical Systems|KRMD - Enterprise Value
- book capitalization data:
Equity per Share KORU Medical Systems|KRMD - Company Book Value|Market Cap to Net Assets Ratio korumedical.com|KRMD - Company Total Assets
- debt and liquidity data:
Debt to Capital KORU Medical Systems|KRMD - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio KORU Medical Systems, Inc.|KRMD - Company Aggregate Debts|Debts to Net Assets KORU Medical Systems|KRMD - Company Long-Term Debts|Company Current Liabilities KORU Medical Systems
General company analysis:KRMD (KORU Medical Systems)
Original product of KORU Medical Systems

Enterprise Value (EV) represents the aggregate value of KORU Medical Systems (KRMD), combining market capitalization with net debt to determine the actual acquisition price of the business. Analyzing changes in EV levels allows for portfolio stress-testing by comparing capitalization against the costs of plastic environmental disposal and plant modernization, which is critical for assessing the sustainability of this infusion systems manufacturer.

Competitor analysis for KORU Medical Systems

Intuitive Surgical, Inc. - Value Adjusted for Debt and Cash|DHR: Total Company Value|BDX - Real Price to Acquire Entire Company|Enterprise Value STERIS plc|WST (westpharma.com) - Business Value|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Teknova Inc TKNO|Enterprise Value MGRM (Monogram Technologies)|STSS: Company Buyout Price|Total Company Value infusystem.com|UTMD (Utah Medical Products Inc.) - Business Value|NYXH: Total Company Value|Company Buyout Price Microbot Medical, Inc (MBOT)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)